Published in Cancer Weekly, October 28th, 1996
P829 is a unique combination of a synthetic peptide designed to attach to targeted diseased tissues and technetium-99m, a radioactive material detected by the gamma cameras now used by hospitals throughout the U.S. and in other parts of the world. P829 is expected to be more accurate and significantly less expensive than computerized tomography, the primary procedure currently used to identify melanoma, neuroendocrine, breast and lung tumors.
The first of the 260 patients enrolled...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.